Rezolut Medical Imaging

Rezolut Medical Imaging

One Equity Partners formed Rezolut in 2020 as a platform to consolidate the fragmented US outpatient diagnostic imaging market. The firm pursues a buy-and-build strategy anchored in acquiring independent, community-based imaging centers, centralizing back-office functions, and deploying advanced modalities including MRI, CT, ultrasound, and digital X-ray. Rezolut's footprint spans multiple states, with concentrated presences in the Southeast and Mid-Atlantic regions, where it operates under legacy practice names to retain local physician relationships and patient referral patterns. The platform competes directly with hospital-based radiology departments and publicly traded consolidators such as RadNet. Rezolut's deal cadence relies on identifying founder-owned imaging centers nearing succession transitions. The firm integrates acquired locations through shared IT infrastructure, payer contracting scale, and a teleradiology network that distributes reads across its employed radiologist base. Representative tuck-in acquisitions include Advanced Imaging of Port Charlotte (Florida, 2021) and Diagnostic Imaging of Milford (Pennsylvania, 2022). Rezolut's geographic concentration advantages lower radiology coverage costs relative to a national footprint while still offering referring physicians multi-site access for patients requiring different exam types. The firm negotiates with commercial payers on a regional basis, leveraging combined volumes across its cluster markets. One Equity Partners, the middle-market private equity sponsor backing Rezolut, manages approximately $10 billion in assets (per OEP, 2023) and has substantial healthcare services experience across prior portfolio companies. Rezolut's management team includes imaging-industry operators with backgrounds at regional radiology groups and health system joint-venture imaging partnerships. The platform represents an estimated deployment of $150–300 million in committed equity and acquisition financing since inception, though exact figures remain private. In January 2024, Rezolut recruited a new Chief Development Officer from a competing consolidator to lead its next expansion phase into Texas and the Carolinas. Rezolut's structural differentiator is its deliberately localized branding model — acquired centers retain their original practice names rather than converting to a single national consumer identity. This preserves referring-physician loyalty, which in radiology drives roughly 80% of scheduled exam volume. The approach mirrors the physician-practice management playbook proven in dental and dermatology roll-ups, adapted for the capital-intensive imaging vertical where equipment refresh cycles and site-level MRI utilization rates define margin profiles more than any corporate brand.